Bangkok Genomics Innovation PCL (BKK:BKGI) EBIT per Share : ฿0.08 (TTM As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL EBIT per Share?

Bangkok Genomics Innovation PCL's EBIT per Share for the three months ended in Sep. 2024 was ฿0.03. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ฿0.08.

During the past 12 months, the average EBIT per Share Growth Rate of Bangkok Genomics Innovation PCL was 64.00% per year. During the past 3 years, the average EBIT per Share Growth Rate was 32.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Bangkok Genomics Innovation PCL's EBIT per Share or its related term are showing as below:

BKK:BKGI' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 32.6 Med: 32.6 Max: 32.6
Current: 32.6

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Bangkok Genomics Innovation PCL was 32.60% per year. The lowest was 32.60% per year. And the median was 32.60% per year.

BKK:BKGI's 3-Year EBIT Growth Rate is ranked better than
84.88% of 172 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.05 vs BKK:BKGI: 32.60

Bangkok Genomics Innovation PCL's EBIT for the three months ended in Sep. 2024 was ฿15.1 Mil.

Bangkok Genomics Innovation PCL EBIT per Share Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL EBIT per Share Chart

Bangkok Genomics Innovation PCL Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

0.02

0.18

0.13

0.06

Bangkok Genomics Innovation PCL Quarterly Data
	Dec20	Dec21	Mar22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial						0.02	0.01	0.02	0.02	0.03

Bangkok Genomics Innovation PCL EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Bangkok Genomics Innovation PCL's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	33.584	/	600.000
=	0.06

Bangkok Genomics Innovation PCL's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	15.142	/	600.000
=	0.03

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.08

Bangkok Genomics Innovation PCL (BKK:BKGI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Bangkok Genomics Innovation PCL EBIT per Share Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Bangkok Genomics Innovation PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110

Website

https://www.bangkokgenomics.com

Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Scientific testing services which generates key revenue, and Sale of goods.